GMAB

Genmab A/S NASDAQ

Healthcare ·Biotechnology ·DK · genmab.com

$27.04

Mkt Cap $16.7B

52w Low $18.89 49.3% of range 52w High $35.43

50d MA $27.41 200d MA $28.79

P/E (TTM) 17.1x

EV/EBITDA 17.3x

P/B 2.8x

Debt/Equity 0.9x

ROE —

P/FCF 16.6x

RSI (14) —

ATR (14) —

Beta 0.74

50d MA $27.41

200d MA $28.79

Avg Volume 1.6M

About

Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphocytic leukemia (CLL) and multiple sclerosis; and Amiva…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Feb 17, 2026	AMC	0.46	0.05	-89.1%	30.00	-2.5%	-2.8%	-3.7%	-2.4%	-2.4%	-2.0%	-14.2%	—
Nov 6, 2025	AMC	0.48	0.65	+35.4%	28.84	-0.4%	-0.6%	+0.8%	+5.1%	+5.7%	+4.9%	+10.7%	—
Aug 7, 2025	AMC	0.39	0.54	+38.5%	22.69	-5.9%	-5.6%	-7.1%	-3.6%	-0.1%	+1.3%	+21.4%	—
May 8, 2025	AMC	0.23	0.31	+34.8%	19.42	+1.0%	-0.3%	+2.6%	-0.6%	-1.8%	+1.2%	+14.6%	—
Feb 12, 2025	AMC	0.28	0.57	+103.6%	19.69	+2.1%	+6.2%	+8.2%	+10.6%	+11.6%	+14.0%	+4.2%	—
Nov 6, 2024	AMC	0.35	0.29	-17.1%	22.33	+1.4%	+3.5%	+3.4%	+3.9%	+0.6%	-3.0%	-2.3%	—
Aug 8, 2024	AMC	0.29	0.22	-24.1%	27.07	-1.8%	-2.4%	-2.1%	-1.8%	-1.0%	+0.5%	+1.4%	—
May 2, 2024	AMC	0.16	0.16	+0.0%	27.72	+7.3%	+7.2%	+4.7%	+5.7%	+3.9%	+3.9%	+4.0%	—
Feb 14, 2024	AMC	0.34	0.36	+5.9%	27.59	+5.3%	+2.3%	+4.1%	+4.9%	+4.9%	+5.5%	+8.5%	—
Nov 7, 2023	AMC	3.14	0.47	-85.0%	29.52	+7.4%	+5.0%	+5.6%	+6.5%	+8.9%	+9.7%	+9.6%	—
Aug 3, 2023	AMC	2.18	0.30	-86.2%	39.28	-4.6%	-4.8%	-4.3%	-4.4%	-3.8%	-4.2%	-3.3%	—
May 10, 2023	AMC	0.65	0.05	-92.3%	40.35	+4.3%	+4.0%	+3.3%	+4.4%	+3.0%	+2.6%	-4.6%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 30	HC Wainwright & Co.	Maintains	Buy → Buy	—	$26.11	$26.46	+1.3%	+1.6%	+1.3%	—	—	—
Apr 22	Goldman Sachs	Upgrade	Neutral → Buy	—	$27.06	$28.05	+3.7%	+2.3%	-0.3%	-0.7%	-1.6%	-1.0%
Feb 23	Guggenheim	Maintains	Buy → Buy	—	$29.29	$28.43	-2.9%	-0.1%	+0.4%	+0.0%	-0.2%	+0.5%
Feb 18	HC Wainwright & Co.	Maintains	Buy → Buy	—	$30.00	$29.25	-2.5%	-2.8%	-3.7%	-2.4%	-2.4%	-2.0%
Jan 28	HC Wainwright & Co.	Maintains	Buy → Buy	—	$34.40	$33.02	-4.0%	-4.3%	-3.1%	-5.1%	-3.3%	-4.0%
Jan 20	HC Wainwright & Co.	Maintains	Buy → Buy	—	$32.25	$31.38	-2.7%	-2.9%	+2.2%	+2.6%	+5.1%	+3.8%
Nov 10	HC Wainwright & Co.	Maintains	Buy → Buy	—	$28.66	$29.36	+2.4%	+1.4%	+5.8%	+6.3%	+5.5%	+5.6%
Nov 7	Truist	Maintains	Buy → Buy	—	$28.84	$28.73	-0.4%	-0.6%	+0.8%	+5.1%	+5.7%	+4.9%
Oct 15	HC Wainwright & Co.	Maintains	Buy → Buy	—	$32.75	$32.53	-0.7%	-0.1%	+0.0%	+1.3%	-6.7%	-8.0%
Oct 2	HC Wainwright & Co.	Maintains	Buy → Buy	—	$31.77	$32.00	+0.7%	+1.1%	+5.6%	+4.8%	+2.7%	+3.1%
Sep 24	Guggenheim	Upgrade	Neutral → Buy	—	$28.73	$28.98	+0.9%	+2.5%	+0.4%	+1.2%	+2.1%	+6.8%
Sep 23	Guggenheim	Upgrade	Neutral → Buy	—	$28.60	$28.70	+0.3%	+0.5%	+3.0%	+0.8%	+1.6%	+2.6%
Aug 15	HC Wainwright & Co.	Maintains	Buy → Buy	—	$22.98	$23.36	+1.7%	+1.4%	+1.9%	+3.7%	+4.7%	+6.3%
Jul 8	Truist	Maintains	Buy → Buy	—	$20.52	$20.84	+1.6%	+3.6%	+5.2%	+6.5%	+4.3%	+4.6%
May 13	HC Wainwright & Co.	Maintains	Buy → Buy	—	$19.93	$19.52	-2.1%	-3.1%	-4.3%	-1.4%	-0.3%	+1.3%
Apr 9	HC Wainwright & Co.	Maintains	Buy → Buy	—	$17.98	$17.71	-1.5%	+4.7%	+0.2%	+4.6%	+7.5%	+8.5%
Mar 11	William Blair	Upgrade	Market Perform → Outperform	—	$21.98	$20.71	-5.8%	-7.8%	-8.1%	-9.2%	-6.7%	-5.4%
Mar 11	Truist	Maintains	Buy → Buy	—	$21.98	$20.71	-5.8%	-7.8%	-8.1%	-9.2%	-6.7%	-5.4%
Feb 13	Leerink Partners	Upgrade	Market Perform → Outperform	—	$19.69	$20.11	+2.1%	+6.2%	+8.2%	+10.6%	+11.6%	+14.0%
Jan 23	HC Wainwright & Co.	Maintains	Buy → Buy	—	$20.97	$21.26	+1.4%	+1.5%	+0.8%	-0.8%	-6.6%	-5.3%
Jan 22	HC Wainwright & Co.	Maintains	Buy → Buy	—	$21.80	$21.52	-1.3%	-3.8%	-2.3%	-3.1%	-4.6%	-10.2%
Jan 8	HC Wainwright & Co.	Maintains	Buy → Buy	—	$22.18	$22.15	-0.1%	+0.0%	-0.1%	-2.1%	-2.4%	-8.8%
Nov 8	BMO Capital	Maintains	Outperform → Outperform	—	$23.11	$22.85	-1.1%	-0.1%	+0.4%	-2.8%	-6.3%	-8.4%
Oct 16	HC Wainwright & Co.	Maintains	Buy → Buy	—	$23.18	$22.83	-1.5%	-2.5%	-0.9%	-0.9%	-1.7%	-1.8%
Sep 20	HC Wainwright & Co.	Maintains	Buy → Buy	—	$26.48	$25.92	-2.1%	-3.6%	-8.8%	-9.3%	-10.0%	-8.9%
Sep 16	HC Wainwright & Co.	Maintains	Buy → Buy	—	$26.90	$26.75	-0.6%	-1.2%	-1.7%	-2.6%	-1.6%	-5.1%
Sep 13	HC Wainwright & Co.	Maintains	Buy → Buy	—	$26.49	$26.55	+0.2%	+1.5%	+0.3%	-0.2%	-1.1%	-0.0%
Sep 11	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$27.50	$27.15	-1.3%	-2.1%	-3.7%	-2.2%	-3.3%	-3.9%
Sep 9	Truist	Maintains	Buy → Buy	—	$27.52	$27.39	-0.5%	-0.2%	-0.1%	-2.1%	-3.7%	-2.3%
Aug 27	HC Wainwright & Co.	Maintains	Buy → Buy	—	$27.36	$27.79	+1.6%	+1.9%	+1.2%	+1.6%	+1.6%	+0.2%
Aug 20	JP Morgan	Downgrade	Overweight → Neutral	—	$27.75	$26.81	-3.4%	-2.0%	-0.9%	-2.6%	-1.5%	-1.4%
Aug 20	HC Wainwright & Co.	Maintains	Buy → Buy	—	$27.75	$26.81	-3.4%	-2.0%	-0.9%	-2.6%	-1.5%	-1.4%
Aug 9	HC Wainwright & Co.	Maintains	Buy → Buy	—	$27.07	$26.59	-1.8%	-2.4%	-2.1%	-1.8%	-1.0%	+0.5%
Aug 6	HC Wainwright & Co.	Maintains	Buy → Buy	—	$26.07	$26.38	+1.2%	+1.5%	+1.5%	+3.8%	+1.4%	+1.7%
Aug 1	HC Wainwright & Co.	Maintains	Buy → Buy	—	$28.29	$28.33	+0.1%	+0.2%	-0.2%	-7.8%	-6.4%	-6.5%
Jul 18	HC Wainwright & Co.	Maintains	Buy → Buy	—	$26.83	$27.19	+1.3%	+1.5%	+3.4%	+3.6%	+4.1%	+3.9%
Jul 15	RBC Capital	Upgrade	Sector Perform → Outperform	—	$27.05	$26.53	-1.9%	-1.9%	-0.2%	-0.8%	+0.7%	+2.6%
Jun 27	BTIG	Maintains	Buy → Buy	—	$25.67	$25.72	+0.2%	-0.4%	-2.1%	-3.2%	-3.0%	-2.0%
Jun 27	HC Wainwright & Co.	Maintains	Buy → Buy	—	$25.67	$25.72	+0.2%	-0.4%	-2.1%	-3.2%	-3.0%	-2.0%
Jun 20	HC Wainwright & Co.	Maintains	Buy → Buy	—	$25.80	$25.69	-0.4%	+0.3%	+0.9%	+0.1%	-0.1%	-0.5%
Jun 4	Truist	Maintains	Buy → Buy	—	$28.83	$28.46	-1.3%	-1.1%	-0.3%	-1.0%	-3.7%	-3.2%
Jun 3	HC Wainwright & Co.	Maintains	Buy → Buy	—	$28.20	$28.44	+0.9%	+2.2%	+1.1%	+1.9%	+1.2%	-1.5%
May 20	HC Wainwright & Co.	Maintains	Buy → Buy	—	$29.98	$29.83	-0.5%	-1.0%	-2.8%	-0.6%	-2.1%	-6.6%
May 3	HC Wainwright & Co.	Maintains	Buy → Buy	—	$27.72	$29.73	+7.3%	+7.2%	+4.7%	+5.7%	+3.9%	+3.9%
Apr 30	HC Wainwright & Co.	Maintains	Buy → Buy	—	$28.57	$27.94	-2.2%	-3.1%	+0.6%	-3.0%	+4.0%	+1.6%
Apr 4	HC Wainwright & Co.	Maintains	Buy → Buy	—	$29.30	$30.32	+3.5%	+1.2%	+1.6%	+1.9%	+2.3%	+2.2%
Mar 27	HC Wainwright & Co.	Maintains	Buy → Buy	—	$30.83	$30.50	-1.1%	-0.6%	-3.0%	-1.8%	-2.8%	-5.0%
Mar 26	Truist	Maintains	Buy → Buy	—	$29.98	$30.92	+3.1%	+2.8%	+2.2%	-0.2%	+1.0%	-0.1%
Mar 26	Morgan Stanley	Maintains	Underweight → Underweight	—	$29.98	$30.92	+3.1%	+2.8%	+2.2%	-0.2%	+1.0%	-0.1%
Mar 6	HC Wainwright & Co.	Maintains	Buy → Buy	—	$28.75	$28.92	+0.6%	+0.4%	+2.3%	+5.4%	+10.2%	+9.3%

Data updated apr 26, 2026 10:42am · Source: massive.com